Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,585 signal articles · 328 in last 24h · 112,405 total before filter · latest 37m ago

328last 24h

2141last 7d

379● bullish (7d)

188● bearish (7d)

204publishers

All Macro296 Earnings1216 M&A91 Regulatory23 Product13 Analyst20

✕ clear all filtersticker: JPMsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Investing.com63d agobullish

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Investing.com -- Illumina received a bullish rating upgrade from JPMorgan, which raised its recommendation to Overweight from Neutral and lifted its December 2026 price target to $185 from $125, citing growing confidence in the DNA sequencing company's ability to sustain strong growth despite increasing competition.

JPM